This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Desjarlais,_J.R.
There is no page with the exact title "Desjarlais,_J.R.". The search results for "Desjarlais,_J.R." are displayed below. You can create a page titled Desjarlais,_J.R. (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Desjarlais RL (44 bytes)
1: List of pages with the keyword Desjarlais RL - Category:Desjarlais JR (44 bytes)
1: List of pages with the keyword Desjarlais JR - Category:Desjarlais, J R (46 bytes)
1: List of pages with the keyword Desjarlais, J R - Category:Desjarlais, R L (46 bytes)
1: List of pages with the keyword Desjarlais, R L - Category:Desjarlais, J (44 bytes)
1: List of pages with the keyword Desjarlais, J - Category:DesJarlais, R L (46 bytes)
1: List of pages with the keyword DesJarlais, R L - Category:Desjarlais J (43 bytes)
1: List of pages with the keyword Desjarlais J - Category:DesJarlais RL (44 bytes)
1: List of pages with the keyword DesJarlais RL
Page text matches
- 1ayu (5,135 bytes)
2: ...TH A COVALENT SYMMETRIC BISCARBOHYDRAZIDE INHIBITOR==
3: ...aption='[[1ayu]], [[Resolution|resolution]] 2.20Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1AYU FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.2Å</td></tr> - 1ayv (5,183 bytes)
2: ... COMPLEX WITH A COVALENT THIAZOLHYDRAZIDE INHIBITOR==
3: ...aption='[[1ayv]], [[Resolution|resolution]] 2.30Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1AYV FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.3Å</td></tr> - 1ayw (5,157 bytes)
2: ...A COVALENT BENZYLOXYBENZOYLCARBOHYDRAZIDE INHIBITOR==
3: ...aption='[[1ayw]], [[Resolution|resolution]] 2.40Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1AYW FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.4Å</td></tr> - 1bgo (3,559 bytes)
2: ...IN COMPLEX WITH A COVALENT PEPTIDOMIMETIC INHIBITOR==
3: ...aption='[[1bgo]], [[Resolution|resolution]] 2.30Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1BGO FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.3Å</td></tr> - 1by8 (4,922 bytes)
2: ==THE CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN K==
3: ...aption='[[1by8]], [[Resolution|resolution]] 2.60Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1BY8 FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.6Å</td></tr> - 1c3t (3,694 bytes)
2: ...ROTAMER STRAIN AS A DETERMINANT OF PROTEIN STRUCTURAL SPECIFICITY==
3: <StructureSection load='1c3t' size='340' side='right'caption='[[1c3t]]' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1C3T FirstGlance]. <br>
6: ...ss="sblockDat" id="methodDat">Solution NMR</td></tr> - 2ajl (5,048 bytes)
2: ...ovel Biaryl-Based Dipeptidyl peptidase IV inhibitor==
3: ...aption='[[2ajl]], [[Resolution|resolution]] 2.50Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2AJL FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.5Å</td></tr> - Category:Desjarlais RL (44 bytes)
1: List of pages with the keyword Desjarlais RL - 1bp4 (4,741 bytes)
2: ...RUCTURES OF TWO PAPAIN INHIBITOR COMPLEXES DEMONSTRATE BINDING TO S'-SUBSITES.==
3: ...aption='[[1bp4]], [[Resolution|resolution]] 2.20Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1BP4 FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.2Å</td></tr> - 1bqi (4,715 bytes)
2: ...RUCTURES OF TWO PAPAIN INHIBITOR COMPLEXES DEMONSTRATE BINDING TO S'-SUBSITES.==
3: ...aption='[[1bqi]], [[Resolution|resolution]] 2.50Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1BQI FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.5Å</td></tr> - 1enh (2,538 bytes)
2: ==STRUCTURAL STUDIES OF THE ENGRAILED HOMEODOMAIN==
3: ...aption='[[1enh]], [[Resolution|resolution]] 2.10Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1ENH FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.1Å</td></tr> - Category:Desjarlais JR (44 bytes)
1: List of pages with the keyword Desjarlais JR - 2i08 (3,631 bytes)
2: ... of EF-hand proteins: X-ray structure of Ca2+-saturated double mutant Q41L-K75I of N-domain of calmod...
3: ...aption='[[2i08]], [[Resolution|resolution]] 2.00Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2I08 FirstGlance]. <br>
6: ...action, [[Resolution|Resolution]] 2Å</td></tr> - 1ud7 (5,656 bytes)
2: ...=SOLUTION STRUCTURE OF THE DESIGNED HYDROPHOBIC CORE MUTANT OF UBIQUITIN, 1D7==
3: <StructureSection load='1ud7' size='340' side='right'caption='[[1ud7]]' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1UD7 FirstGlance]. <br>
6: ...ss="sblockDat" id="methodDat">Solution NMR</td></tr> - 3bea (10,283 bytes)
2: ...KID) in complex with a pyrimidinopyridone inhibitor==
3: ...aption='[[3bea]], [[Resolution|resolution]] 2.02Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3BEA FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 2.02Å</td></tr> - 3dpk (13,604 bytes)
2: ...nase in complex with a pyridopyrimidinone inhibitor==
3: ...aption='[[3dpk]], [[Resolution|resolution]] 1.95Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3DPK FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.95Å</td></tr> - 3krj (13,057 bytes)
2: ...dazole-2-carboxylic acid (2-cyclohex-1-enyl-4-piperidin-4-yl-phenyl)-amide==
3: ...aption='[[3krj]], [[Resolution|resolution]] 2.10Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3KRJ FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.1Å</td></tr> - 3krl (12,961 bytes)
2: ...arboxylic acid [4-(4-methyl-piperazin-1-yl)-2-piperidin-1-yl-phenyl]-amide==
3: ...aption='[[3krl]], [[Resolution|resolution]] 2.40Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3KRL FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.4Å</td></tr> - 3pe6 (3,741 bytes)
2: ...ble form of human MGLL in complex with an inhibitor==
3: ...aption='[[3pe6]], [[Resolution|resolution]] 1.35Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3PE6 FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.35Å</td></tr> - User:Anthony Davis/Sandbox1 IgE (6,380 bytes)
1: ...eptor FcϵRI' scene='Insert optional scene name here' />[[Image:1F2Q]]
3: =IgE Receptor FcϵRI=
4: ...t cells for example, shown below is responsible for the binding of IgE.
10: ...s/immuneSystem/Pages/disordersImages.aspx#allergicreaction]
12: ...tamines, topical nasal steroids, cromolyn sodium or decongestants.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
